Clinical Trial Update: COVID-19 Vaccine For Indirect Protection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating a COVID-19 vaccine for indirect protection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaccine-preventable Diseases

Snippet

Sponsor: McMaster University | Conditions: Vaccine Preventable Disease | Phase 4 | Status: WITHDRAWN